Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Bispebjerg Hospital25 enrolled

Overview

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation, if partial or no response after 3 months the treatment was repeated. Follow-up 3 and 12 months after last treatment.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Basal Cell Carcinoma

Interventions

Calcium chlorideDRUG

Calcium electroporation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Primary low risk basal cell carcinoma less than 3 cm in diameter \- Exclusion Criteria: Immunosuppression or organ transplant recipients Pregnancy or breastfeeding Allergy to local anesthetics

Locations (1)

Department of Dermatology, Bispebjerg Hospital

Copenhagen, Denmark

RECRUITING

Outcomes

Primary Outcomes

complete response

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.